...
Product Theater – Let’s Talk About an Option for Your Patients with Challenging Manifestations of Psoriasis
November 23, 2019

Faculty: Michael Shane Chapman, MD Dr. Michael Chapman presented the afternoon product theater reviewing Otezla (apremilast). Otezla is indicated for the treatment of adult patients with active psoriatic arthritis and patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. He mentioned we should approach “psoriasis as a systemic condition …

...
CVD and Psoriasis: Is One Treatment Better Than Another to Reduce Risk?
August 1, 2018

Psoriasis is a known risk factor for cardiovascular events such as myocardial infarction, coronary heart disease, stroke, and thromboembolism and mortality attributed to cardiovascular disease (CVD) increases with the severity of psoriasis. One hypothesis for how these two diseases are connected is that pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a) may be a pathogenic …